Facebook
X
LinkedIn
Forward
Unpacking the Data: The Application and Interpretation of Real-World Evidence in GLP-1 Obesity Treatment
Webinar recorded on Wednesday, May 13, 2026 at 11 am-12 pm ET Pricing: Free for Members and $99 for Non-Members
Program Description
GLP-1 agonists to treat obesity continue to challenge health plan sponsors as a major contributor to prescription drug spending, leading to widespread variation in coverage among health plans and employer groups. GLP-1 treatments for obesity hold the potential for improved health outcomes which could offset increasing prescription drug spending through reductions in medical costs. However, real-world evidence on this connection remains limited, with seemingly contradictory findings across analyses. Variation in study design and assessment contributes to these differences, creating challenges for managed care professionals seeking to leverage this evidence when making coverage decisions. This presentation will address the existing knowledge gap by reviewing the real-world evidence on GLP-1 products for obesity, exploring how variation in the design of these studies affects results, and describing how managed care decision-makers can leverage current evidence to inform GLP-1 coverage decisions.
Target Audience
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss the real-world evidence on the relationship between GLP-1 initiation, health care outcomes, and health care spending among members with obesity.
- Identify how differences in the designs of real-world studies affect findings.
- Describe how managed care decision makers can use real-world evidence to inform GLP-1 coverage.
Speakers:
Janna Evans, PharmD
Director, Pharmacy Sales and Account Management
Blue Cross and Blue Shield of Texas
Landon Z. Marshall, PharmD, PhD
Principal Health Outcomes Researcher
Prime Therapeutics
Ben Urick, PharmD, PhD
Senior Director of Health Outcomes
Prime Therapeutics
Moderator:
Amy Heck Sheehan, PharmD
Professor of the Department of Pharmacy Practice
Purdue University
Financial Relationship Disclosures:
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Janna Evans Faculty | Disclosed no relevant financial relationships |
| Landon Marshal Faculty | Employer PBM: Prime Therapeutics employee, not in disqualifying role |
| Ben Urick Faculty | Employer PBM: Prime Therapeutics employee, not in a disqualifying role |
| Shyra Bias Peer Reviewer | Employer PBM: CVS Health employee, not in a disqualifying role |
| Jennifer L. Evans Planner | Disclosed no relevant financial relationships |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN: 0233-0000-26-032-H01-P
Activity Type: Knowledge-Based
Contact Hours: 1.00
Release Date: May 13, 2026
Expiration Date: December 31, 2027
Activity Fee: Free for Members and $99 for Non-Members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.